BSGM BioSig Technologies, Inc. Stock Quote

BSGM [NASD]

Index	-	P/E	-	EPS (ttm)	-1.90	Insider Own	8.20%	Shs Outstand	30.93M	Perf Week	3.74%
Market Cap	109.02M	Forward P/E	-	EPS next Y	-0.28	Insider Trans	-2.95%	Shs Float	23.25M	Perf Month	-17.78%
Income	-52.20M	PEG	-	EPS next Q	-0.15	Inst Own	17.20%	Short Float	12.13%	Perf Quarter	-39.67%
Sales	-	P/S	-	EPS this Y	-13.70%	Inst Trans	-0.30%	Short Ratio	11.39	Perf Half Y	-7.50%
Book/sh	0.79	P/B	4.22	EPS next Y	51.70%	ROA	-169.90%	Target Price	-	Perf Year	-70.53%
Cash/sh	0.86	P/C	3.85	EPS next 5Y	-	ROE	-206.10%	52W Range	2.79 - 12.19	Perf YTD	-14.62%
Dividend	-	P/FCF	-	EPS past 5Y	-1.50%	ROI	-	52W High	-72.68%	Beta	1.74
Dividend %	-	Quick Ratio	5.60	Sales past 5Y	-	Gross Margin	-	52W Low	19.35%	ATR	0.29
Employees	49	Current Ratio	5.70	Sales Q/Q	-	Oper. Margin	-	RSI (14)	43.04	Volatility	8.77% 8.68%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	49.60%	Profit Margin	-	Rel Volume	1.01	Prev Close	3.19
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	247.50K	Price	3.33
Recom	2.00	SMA20	-3.51%	SMA50	-17.73%	SMA200	-33.98%	Volume	249,457	Change	4.39%

Mar-30-20

Initiated

ROTH Capital

Buy

May-04-21 06:28PM	BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System Benzinga
09:15AM	BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System GlobeNewswire
May-03-21 12:00PM	BioSig Technologies, Inc. Invited to Present at Wall Street Conference GlobeNewswire
01:56AM	Is BioSig Technologies, Inc.'s (NASDAQ:BSGM) Shareholder Ownership Skewed Towards Insiders? Simply Wall St.
Apr-27-21 09:30AM	BioSigs PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona GlobeNewswire
Apr-15-21 11:45AM	BioSig Expands Commercial Team in Two Strategic Regions GlobeNewswire
Apr-14-21 09:29AM	BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform GlobeNewswire
Apr-13-21 09:32AM	BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study GlobeNewswire
Apr-09-21 09:32AM	BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH) GlobeNewswire
Apr-08-21 09:32AM	EP Lab Digest Features Physician Experience with BioSigs Cardiac Signal Acquisition Technology GlobeNewswire +6.41%
Apr-06-21 09:45AM	BioSig lands Commercial Sales to Leading Hospital System GlobeNewswire
Apr-05-21 10:00AM	BioSig Technologies, Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference GlobeNewswire +6.03%
Mar-30-21 08:30AM	BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing Technology GlobeNewswire +5.58%
Mar-29-21 09:15AM	BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021 GlobeNewswire
Mar-19-21 12:15PM	BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference GlobeNewswire
Mar-10-21 05:30PM	BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference GlobeNewswire
Mar-09-21 04:45PM	BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH Conference GlobeNewswire +9.16%
Mar-05-21 09:44AM	The Future of Medicine is Here: Bioelectronic Medicine Benzinga
Mar-04-21 09:15AM	BioSig Awarded U.S. Patent Claims for its NeuroClear Subsidiary GlobeNewswire
Feb-16-21 08:45AM	BioSig Appoints Brenda Castrodad to Lead Human Resources GlobeNewswire -5.25%
Feb-11-21 08:30AM	Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 PR Newswire +5.34%
Feb-10-21 10:00AM	Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP Systems GlobeNewswire
Feb-08-21 08:35AM	Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing PR Newswire
Feb-02-21 08:00AM	BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP System GlobeNewswire
Jan-28-21 08:35AM	Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th PR Newswire
Jan-27-21 04:30PM	BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor Conference Small and Microcap Showcase GlobeNewswire
Jan-15-21 09:32AM	BioSig to Present at the 26th Annual International AF Symposium GlobeNewswire -8.71%
Jan-14-21 09:32AM	BioSig PURE EP System Featured in the Editorial of EP Lab Digest GlobeNewswire
Jan-13-21 01:35PM	Why Vuzix Stock Popped Today Motley Fool +8.01%
09:32AM	BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions GlobeNewswire
07:00AM	Sidoti Virtual Investor Conference ACCESSWIRE
Jan-12-21 09:32AM	BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana GlobeNewswire +13.53%
Jan-11-21 12:13AM	Are Insiders Buying BioSig Technologies, Inc. (NASDAQ:BSGM) Stock? Simply Wall St.
Jan-06-21 10:00AM	BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter 2021 Investor Conference GlobeNewswire +7.67%
Dec-18-20 08:30AM	BioSigs Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota GlobeNewswire
Dec-16-20 09:45AM	BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System Benzinga -5.27%
Dec-11-20 07:51AM	BioSig Announces First Sale Of Cardiac Signal Processing Systems Benzinga +8.83%
07:30AM	BioSig Achieves First Commercial Sale of Three PURE EP Systems GlobeNewswire
Dec-10-20 03:00PM	BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD Micro Main Event Conference GlobeNewswire +6.56%
Dec-03-20 11:00AM	BioSig to Highlight PURE EP System at the Benzinga Global Small Cap Conference GlobeNewswire
Dec-02-20 11:41AM	Insider Buys BioSig Technologies Stock Benzinga
Nov-30-20 11:00AM	BioSigs PURE EP System to Support Live Patient Cases during EPLive 2020 GlobeNewswire
Nov-19-20 11:32AM	Insider Buys BioSig Technologies Shares Benzinga +5.03%
Nov-12-20 02:11PM	BioSig to Host Business Update Conference Call on November 18, 2020 GlobeNewswire
05:56AM	Is BioSig Technologies (NASDAQ:BSGM) In A Good Position To Invest In Growth? Simply Wall St.
Oct-29-20 02:05PM	BioSig Announces Completion of PURE EP System Installation at New Medical Center GlobeNewswire
Oct-28-20 10:00AM	BioSig Issues October 2020 Shareholder Update Letter GlobeNewswire +12.54%
Oct-26-20 11:04AM	Biosig stock plunges to lead Nasdaq losers after trial of COVID-19 treatment halted MarketWatch -39.64%
07:30AM	ViralClear halts its Phase 2 Hospitalized COVID-19 Trial GlobeNewswire
Sep-30-20 09:27AM	SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19 GlobeNewswire
Sep-22-20 10:55AM	ViralClear Expands Ongoing Phase 2 Trial Size for its Oral Anti-Viral for the Treatment of COVID-19, Expands Trial Locations and Appoints Contract Manufacturing Organization to Manufacture Phase 3 Supplies of Merimepodib Oral Solution GlobeNewswire -33.66%
Sep-21-20 11:01AM	Reminder: ViralClear to Host Conference Call and Webcast on September 22, 2020 to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19 GlobeNewswire -5.35%
Sep-15-20 10:00AM	BioSig Releases PURE EP Study Abstract with Data Presented at European Society of Cardiologys ESC Congress 2020 GlobeNewswire +7.29%
Sep-14-20 03:00PM	BioSig Announces Abstract Acceptance to Computing in Cardiology 2020 GlobeNewswire
10:29AM	Reminder: BioSig to Host Conference Call and Webcast on September 15, 2020 to Discuss Unblinding of PURE EP Human Data GlobeNewswire
Sep-09-20 12:15PM	ViralClear to Host Conference Call on September 22, 2020, to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19 GlobeNewswire -9.67%
Sep-02-20 10:15AM	BioSig to Host Conference Call on September 15, 2020 to Discuss Unblinding of PURE EP Human Data GlobeNewswire +8.78%
Aug-31-20 05:00PM	LD Micro 360 Companies Set to Present this Week ACCESSWIRE
Aug-25-20 10:45AM	BioSig Technologies to Present at The LD 500 Virtual Conference ACCESSWIRE
08:30AM	BioSig Technologies to Present at The LD 500 Virtual Conference GlobeNewswire
Aug-17-20 12:16PM	Could The BioSig Technologies, Inc. (NASDAQ:BSGM) Ownership Structure Tell Us Something Useful? Simply Wall St.
Aug-06-20 10:00AM	Infectious Diseases Expert Prof. Angus Dalgleish Joins ViralClears Scientific Advisory Board GlobeNewswire
Aug-05-20 02:09PM	ViralClear Appoints Dr. Michael Sofia to Its Scientific Advisory Board GlobeNewswire
11:15AM	LD Micro - Announces Preliminary List of Presenters for the LD-500. ACCESSWIRE
Aug-04-20 09:25AM	BioSig Installs PURE EP(tm) System at Massachusetts General Hospital GlobeNewswire -9.67%
Aug-03-20 02:00PM	BioSig Awarded CAGE Code by the Systems for Award Management (SAM) GlobeNewswire
Jul-30-20 01:00PM	BioSig Technologies to Present at the Proactive Investors One2One Virtual Event on August 4, 2020 GlobeNewswire +9.43%
Jul-23-20 08:30AM	BioSig Technologies to Participate in LD Micros Zooming with LD GlobeNewswire
Jul-20-20 01:50PM	ViralClear Announces Formation of Its Scientific Advisory Board GlobeNewswire
Jul-17-20 02:42PM	BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit GlobeNewswire
Jul-16-20 05:30PM	BioSig Technologies, Inc. Adopts Stockholder Rights Agreement GlobeNewswire +5.86%
11:00AM	'Zooming with LD' to Feature 10 Distinct Companies July 20th-31st ACCESSWIRE
10:30AM	BioSig Technologies, Inc. Adopts Stockholder Rights Agreement GlobeNewswire
Jul-13-20 01:42PM	Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites GlobeNewswire
Jul-10-20 01:15PM	BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government GlobeNewswire
Jul-01-20 09:15AM	BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors GlobeNewswire
Jun-29-20 08:18AM	BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering GlobeNewswire +9.06%
Jun-24-20 09:20AM	BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering GlobeNewswire -21.94%
Jun-22-20 02:30PM	ViralClear Partners with Catalent on Potential Treatment for COVID-19 GlobeNewswire
Jun-17-20 07:55AM	ViralClear Opens Enrollment with First Patient Dosing in Phase II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19 GlobeNewswire +5.29%
Jun-08-20 03:02PM	Reminder - BioSig Subsidiary, ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-Viral Candidate for Treatment of COVID-19 GlobeNewswire +12.02%
Jun-05-20 09:10AM	ViralClear adds St. David's HealthCare in Austin, Texas, to its Planned Phase II trial for its Broad-Spectrum Oral Anti-Viral Candidate for COVID-19 GlobeNewswire
Jun-04-20 09:25AM	BioSig Technologiess PURE EP System to be Presented in Heart Rhythm Society 2020 Science Sessions GlobeNewswire
Jun-03-20 11:45AM	BioSig Technologies Expands Intellectual Property Portfolio GlobeNewswire +7.59%
Jun-01-20 10:42AM	ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-viral Candidate for Treatment of COVID-19 GlobeNewswire +11.73%
May-28-20 08:40AM	Michael R. Dougherty Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc. GlobeNewswire -5.09%
May-20-20 10:12AM	ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib GlobeNewswire
May-18-20 08:32AM	FDA Clears the Investigational New Drug Application to Enable the Phase II Trial of ViralClears Merimepodib, Oral Solution to Treat Adult Patients with Advanced COVID-19, to Proceed GlobeNewswire
May-14-20 08:15AM	ViralClear Publishes in F1000 Research In Vitro Data Demonstrating Synergy between Merimepodib and Remdesivir Against SARS-CoV-2, the Cause of COVID-19 GlobeNewswire
May-07-20 03:17PM	Michael Schmertzler Joins the Board of ViralClear Pharmaceuticals, a Majority-Owned Subsidiary of BioSig Technologies, Inc. GlobeNewswire
May-05-20 02:10PM	Biotech and Investment Veteran Dennis Purcell Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc. GlobeNewswire +6.35%
07:02AM	Could This Under-the-Radar Biotech Piggyback on Gilead's Remdesivir Success? Motley Fool
May-01-20 10:39AM	BioSig Resumes Clinical Activities with PURE EP System GlobeNewswire
Apr-30-20 09:20AM	ViralClear Submits In Vitro Data on Merimepodib and Remdesivir Synergistic Activity Against the COVID-19 Novel Coronavirus to a Peer-Reviewed Journal GlobeNewswire -13.30%
Apr-24-20 02:30PM	BioSig to Host Conference Call on Recent Developments of Subsidiary ViralClear and its Broad-Spectrum Oral Anti-Viral Candidate Merimepodib for the Treatment of COVID-19 GlobeNewswire +12.84%
09:25AM	BioSig Subsidiary ViralClear Submits Investigational New Drug Application to the FDA for Phase II Clinical Trials for Merimepodib, an Orally Administered Treatment for Patients with COVID-19 GlobeNewswire
Apr-23-20 09:15AM	ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research GlobeNewswire +7.08%
Apr-21-20 02:36PM	Tony Zook Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc. GlobeNewswire
10:15AM	BioSig Subsidiary ViralClear Submits Application for Vicromax Through FDAs Coronavirus Treatment Acceleration Program (CTAP) to Seek Acceleration of its Planned Clinical Trials GlobeNewswire
Apr-17-20 02:07PM	BioSig Issues April 2020 Shareholder Update Letter GlobeNewswire +12.72%

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ODONNELL JEFFREY F	Director	Feb 08	Sale	5.12	42,762	219,100	151,629	Feb 09 09:15 PM
ODONNELL JEFFREY F	Director	Feb 05	Sale	5.00	62,238	311,271	194,391	Feb 09 09:15 PM
CHAUSSY STEVE	Chief Financial Officer	Dec 01	Buy	4.35	2,000	8,699	681,128	Dec 02 09:00 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 30	Buy	4.65	2,000	9,300	1,345,558	Dec 02 09:01 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 24	Buy	4.33	1,000	4,330	1,343,558	Nov 25 09:45 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 23	Buy	4.41	3,000	13,230	1,342,558	Nov 25 09:45 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 18	Buy	3.95	4,500	17,755	1,339,558	Nov 19 09:45 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 17	Buy	3.89	4,000	15,545	1,335,058	Nov 19 09:45 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 16	Buy	3.98	5,000	19,900	1,331,058	Nov 17 09:46 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 13	Buy	3.90	2,000	7,800	1,326,058	Nov 16 09:48 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 12	Buy	3.66	5,000	18,300	1,324,058	Nov 13 09:45 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 10	Buy	3.45	7,200	24,807	1,319,058	Nov 12 09:47 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 09	Buy	3.42	16,600	56,816	1,311,858	Nov 10 09:45 AM
LONDONER KENNETH L	Chief Executive Officer	Nov 06	Buy	3.34	12,500	41,765	1,295,258	Nov 09 10:00 AM
LONDONER KENNETH L	Chief Executive Officer	May 29	Buy	9.26	4,000	37,020	1,282,758	May 29 11:30 AM
ZELDIS JEROME B	Director	May 28	Buy	10.49	1,000	10,489	107,944	May 28 10:58 AM
LONDONER KENNETH L	Chief Executive Officer	May 26	Buy	10.84	3,600	39,014	1,278,758	May 26 10:57 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience